Ferring Pharmaceuticals, Inc.
A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis
- Conditions
- Nocturnal Enuresis
- Interventions
- Drug: Primary nocturnal enuresis
- First Posted Date
- 2005-10-28
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 802
- Registration Number
- NCT00245479
- Locations
- 🇫🇷
Foundation Hospital Saint Joseph, 185, rue Raymond Losserand, Paris Cedex 14, France
Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients
- First Posted Date
- 2005-10-28
- Last Posted Date
- 2011-05-20
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 88
- Registration Number
- NCT00245466
Desmopressin Response in the Young
- First Posted Date
- 2005-10-03
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 132
- Registration Number
- NCT00230594
- Locations
- 🇨🇦
The Kids Clinic, Whitby, Ontario, Canada
🇨🇦IWK Health Centre, Halifax, Nova Scotia, Canada
🇨🇦The Male Health Centres, Oakville, Ontario, Canada
A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s Disease
- Conditions
- Crohn's Disease
- First Posted Date
- 2005-09-26
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 50
- Registration Number
- NCT00225810
- Locations
- 🇨🇿
Faculty Hospital Motol, Paediatric Clinic, Prague, Czech Republic
🇨🇿Faculty Hospital Bulovka, Paediatric Clinic, Prague, Czech Republic
Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2011-05-20
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 131
- Registration Number
- NCT00215657
An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2015-04-01
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 137
- Registration Number
- NCT00215683
- Locations
- 🇩🇪
Vivantes Klinikum am Urban, Klinik für Urologie, Berlin, Germany
🇩🇪Urologische Universitätsklinikum, Klinikum Mannheim GmbH, Fakultät für Klinische Medizin Mannheim, Mannheim, Germany
🇭🇺Pez Aladar County Hospital, Dept. of Urology, Györ, Hungary
Study of Effects and of Modifications in Apoptosis Regulators Observed After Stopping 5-ASA Treatment in Patients With Inactive Ulcerative Colitis
- Conditions
- Ulcerative Colitis
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-04-23
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 6
- Registration Number
- NCT00209287
- Locations
- 🇫🇷
Hôpital Saint Antoine, Service d'hépato-Gastroentérologie, Paris, France
A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)
- Conditions
- Primary Nocturnal Enuresis
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 221
- Registration Number
- NCT00209261
- Locations
- 🇫🇷
Service de Chirurrgie Viscerale Pediatrique Hospital Necker-Enfants Malades, Paris, France
Pentasa Once Daily in Ulcerative Colitis for Maintenance of Remission
- Conditions
- Ulcerative Colitis
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 362
- Registration Number
- NCT00209300
- Locations
- 🇧🇪
UZ Gent, Gent, Belgium
🇧🇪Heilig Hart Ziekenhuis, Roeselaere, Belgium
🇨🇿Gastroenterologie MUDr.V.Abrahámová, Poděbrady, Czech Republic
A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor
- Conditions
- Premature BirthLabor, Premature
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2011-12-16
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 163
- Registration Number
- NCT00209326
- Locations
- 🇷🇴
Spitalul Clinic Judetean Cluj-Napoca Ginecologie No. 1, Clinica Nr. 1 Ginecologie Nr. 3-5, Str. Clinicilor, Cluj-Napoca, Romania
🇨🇿Gynekologicka-porodnicka klinika Fakultni nemocnice, Capkovo namesti 1, Plzen, Czech Republic
🇫🇮Kuopio University Hopital, Kuopio, Finland